Our Integrated Drug Discovery division embodies a comprehensive synergy between invitro Biology and invivo research, paving the way for groundbreaking advancements. In our invitro Biology realm, precision reigns supreme as our adept team meticulously engineers assays to unlock the complexities of drug interactions. From inception to refinement, our expertise in assay development spans across diverse therapeutic areas, ensuring tailored assays that elucidate intricate mechanisms.
Our medium and high throughput screening platforms empower thorough investigations, facilitating rapid and comprehensive analyses crucial for discerning promising drug candidates. Moreover, Biomarker Identification initiatives harness cutting-edge methodologies to pinpoint critical indicators, guiding our quest for therapeutic breakthroughs. Mechanism of action studies unravel the intricate workings of compounds, while Reagent Generation fuels our quest for innovative solutions. Shifting gears to our invivo domain, our expertise spans Oncology, Inflammation, Infectious Diseases, Respiratory Diseases, Fibrosis, Pain, Autoimmune Diseases, Metabolic Diseases, and Vaccine Models. Our meticulous research extends to Safety Pharmacology, ensuring rigorous assessments that underpin patient safety and regulatory compliance. This holistic integration of invitro and invivo research forms the cornerstone of our commitment to transformative drug discovery.
